Cytomegalovirus prophylaxis in seropositive renal transplant recipients receiving thymoglobulin induction therapy: Outcome and risk factors for late CMV disease-Reference-Cited by-同舟云学术

Cytomegalovirus prophylaxis in seropositive renal transplant recipients receiving thymoglobulin induction therapy: Outcome and risk factors for late CMV disease

Published:2018-07-02 Issue:5 Volume:20 Page:e12929
ISSN:1398-2273
Container-title:Transplant Infectious Disease
language:en
Short-container-title:Transpl Infect Dis

Author:

Reusing Jose O.¹^ORCID,Feitosa Emanoela B.¹,Agena Fabiana¹,Pierrotti Lígia C.¹,Azevedo Luiz S. F.¹,Kotton Camille N.²,David-Neto Elias¹

Affiliation:

1. Renal Transplantation Service; Hospital das Clínicas; University of Sao Paulo Medical School; São Paulo Brazil

2. Transplant and Immunocompromised Host Infectious Diseases; Harvard Medical School; Infectious Diseases Division; Massachusetts General Hospital; Boston MA USA

Publisher

Wiley

Subject

Infectious Diseases,Transplantation

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/tid.12929/fullpdf

Reference44 articles.

1. Impact of current transplantation management on the development of cytomegalovirus disease after renal transplantation;San Juan;Clin Infect Dis,2008

2. CMV infections after two doses of daclizumab versus thymoglobulin in renal transplant patients receiving mycophenolate mofetil, steroids and delayed cyclosporine A;Abou-Ayache;Nephrol Dial Transplant,2008

3. Symptomatic cytomegalovirus disease in the cytomegalovirus antibody seropositive renal transplant recipient treated with OKT3;Hibberd;Transplantation,1992

4. Prophylactic oral ganciclovir compared with deferred therapy for control of cytomegalovirus in renal transplant recipients;Brennan;Transplantation,1997

5. Updated international consensus guidelines on the management of cytomegalovirus in solid-organ transplantation;Kotton;Transplantation,2013

Cited by 19 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Clinico-epidemiological characteristics of early- versus late-onset cytomegalovirus disease among renal transplant recipients: A two-decade experience;Transplant Immunology;2024-06

2. QuantiFERON-CMV as a Predictor of CMV Events During Preemptive Therapy in CMV-seropositive Kidney Transplant Recipients;Transplantation;2023-11-22

3. Epidemiology, management, and burden of cytomegalovirus in solid organ transplant recipients in selected countries outside of Europe and North America: A systematic review;Transplant Infectious Disease;2023-05-31

4. Incidence and severity of cytomegalovirus infection in seropositive heart transplant recipients;Clinical Transplantation;2023-03-29

5. Relationship between Cytomegalovirus Viremia and Long-Term Outcomes in Kidney Transplant Recipients with Different Donor Ages;Microorganisms;2023-02-11